NCT04100278 Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes Status UNKNOWN Phase NA
NCT04091373 A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide Status COMPLETED Phase PHASE1
NCT04058730 Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG & SMM Status UNKNOWN Phase NA
NCT04047537 Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes Status TERMINATED Phase NA
NCT04029480 Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) Status COMPLETED Phase PHASE3
NCT04027530 Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. Status COMPLETED Phase PHASE4
NCT04014192 Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE4
NCT04013581 Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen Status COMPLETED Phase PHASE4
NCT03997773 Face-it: Health Promotion for Women With Prior Gestational Diabetes Status COMPLETED Phase NA
NCT03992248 Effect of Eating Within a Limited Time on Sugar Sensitivity and Liver Sugar Stores of People With Type 2 Diabetes. Status COMPLETED Phase NA
NCT03986073 Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE2
NCT03983551 Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas Status COMPLETED Phase PHASE4
NCT03962010 A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE2
NCT03961659 Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy. Status UNKNOWN Phase NA
NCT03954834 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Status COMPLETED Phase PHASE3